Close
Nordic 9Nordic 9

OMX Ventures (investor - Venture Capital)

United States omx.vc
See something wrong or missing? Let us know
Offices:Chicago

OMX Ventures is a VC firm investing in early-stage companies building tools and instrumentation for life sciences, and novel platforms for therapeutics.

Average round investment:38.3M USD
Average number per year:1.8
Distribution: 2026 (1)2025 (1)2024 (2)2023 (3)2022 (2)
Portfolio companies: United Kingdom Syndex BioBelgium MRM HealthDenmark Freya Biosciences See the entire list
Mostly invests in: United Kingdom United Kingdom (5) Biotech (8)
See the entire list

Showing 3 of 9 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

OMX Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to OMX Ventures

Name Criteria
United States Data Collective (DCVC)
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United Kingdom Nickleby Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United Kingdom Wilbe Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland MTIP AG
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Belgium
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Belgium European Investment Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
France Merieux Equity Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Belgium
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Global Emerging Markets
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States +ND Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland SkyViews Life Science
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Sunstone Life Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Top